A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
Clinical trial NCT00112281 · TERMINATED
Trial details
- NCT number
- NCT00112281
- Sponsor
- Arginox Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Enrollment
- 658
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.